Document is current
Any future updates will be listed below
-
Authors
Qian, Zhiwen
Jiang, Ying
Cai, Yun
Gao, Erli
Wang, Cenzhu
Dong, Jianfeng
Wang, Fengxu
Liu, Lu
Wu, Danping
Zhang, Feng
Wang, Yida
Ning, Xin
Li, Qi
You, Yilan
Gu, Yanfang
Mei, Jie
Zhao, Xinyuan
Zhang, Yan
-
Funding
Funding for this research was provided by:
General Program of Wuxi Medical Center of Nanjing Medical University (WMCG202354)
Doctoral Talent Fund of the Affiliated Wuxi People’s Hospital of Nanjing Medical University (BSRC202303)
National Natural Science Foundation of China (82472842)
Wuxi Double-Hundred Talent Fund Project (BJ2023075)
- License Information
-
More Information
Article History
Received: 7 June 2025
Accepted: 21 September 2025
First Online: 14 October 2025
Declarations
:
: This study involves human participants and ethical approval for the study of TMAs was granted by the Outdo Biotech Clinical Research Ethics Committee. Ethical approval for the single-cell sequencing data was granted by Clinical Research Ethics Committees at Wuxi Maternal and Child Health Care Hospital (Ethics No. 2024–01-1024–31). Participants gave informed consent to participate in the study before taking part. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Jiangnan University (JN. No 20250228b0720731[069]).
: Not applicable.
: The authors declare no competing interests.
